Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection

Medical Microbiology and Immunology

Volumn 203, Issue 5, 2014, Pages 303-314

  Das, Rumki ^a   Tripathy, Anuradha ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Cytotoxic effector function; HEV; NK NKT like cells; NKG2D; NKp30; NKp44; NKp46

Indexed keywords

BETA INTERFERON; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; TUMOR NECROSIS FACTOR ALPHA; KLRK1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; NCR1 PROTEIN, HUMAN; NCR2 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL ASSAY; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEGRANULATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; FUNCTIONAL STATUS; HEPATITIS E; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS E; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER T-CELLS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; YOUNG ADULT;

EID: 84919480925     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-014-0338-1     Document Type: Article

References (43)

1. Aggarwal R, Jameel S (2011) Hepatitis E. Hepatology 54:2218–2226
2. Krumbholz A, Mohn U, Lange J et al (2012) Prevalence of hepatitis E virus specific antibodies in humans with occupational exposure to pigs. Med Microbiol Immunol 201:239–244
3. Dremsek P, Wenzel JJ, Johne R et al (2012) Seroprevalence study in forestry workers from eastern Germany using novel genotype 3-and rat hepatitis E virus-specific immunoglobulin G ELISAs. Med Microbiol Immunol 201:189–200
4. Srivastava R, Aggarwal R, Jameel S et al (2007) Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein. Viral Immunol 20:56–65
5. Tripathy AS, Das R, Rathod SB, Arankalle VA (2012) Cytokine profiles, CTL response and T cell frequencies in the peripheral blood of acute patients and individuals recovered from Hepatitis E infection. PLoS ONE 7:e31822
6. Yokoyama WM (2008) Mistaken notions about natural killer cells. Nat Immunol 9:481–485
7. Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225–274
8. Biron CA, Brossay L (2001) NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 13:458–464
9. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9:503–510
10. Smyth MJ, Hayakawa Y, Takeda K, Yagita H (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2:850–861
11. Raulet DH (2003) Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3:781–790
12. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223
13. Moretta L, Bottino C, Pende D, Castriconi R, Mingari MC, Moretta A (2006) Surface NK receptors and their ligands on tumor cells. Semin Immunol 18:151–158
14. Fukuda M (1991) Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. J Biol Chem 266:21327–21330
15. Trapani JA, Smyth MJ (2002) Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2:735–747
16. Van Dommelen SL, Degli-Esposti MA (2004) NKT cells and viral immunity. Immunol Cell Biol 82:332–341
17. Peralbo E, Alonso C, Solana R (2007) Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp Gerontol 42:703–708
18. Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ et al (2008) Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus following single source exposure. Gut 57:1121–1128
19. Srivastava R, Aggarwal R, Bhagat MR, Chowdhury A, Naik S (2008) Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E. J Viral Hepat 15:910–916
20. Prabhu SB, Gupta P, Durgapal H, Rath S, Gupta SD et al (2010) Study of cellular immune response against Hepatitis E Virus (HEV). J Viral Hepat 18:587–594
21. Arankalle VA, Lole KS, Deshmukh TM, Chobe LP, Gandhe SS (2007) Evaluation of human (genotype-1) and swine (genotype-4)-ORF-2 based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type-4human HEV infections. J Viral Hepat 14:435–445
22. Saravanabalaji S, Tripathy AS, Dhoot RR, Chadha MS, Kakrani AL, Arankalle VA (2009) Viral load, antibody titers and recombinant open reading frame 2 protein- induced TH1/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E. Intervirology 52:78–85
23. Arankalle VA, Lole KS, Deshmukh TM, Srivastava S, Shaligram US (2009) Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 27:1032–1039
24. Tripathy AS, Das R, Chadha MS, Arankalle VA (2011) Epidemic of Hepatitis B with high mortality in India: association of fulminant disease with lack of CCL4 and natural killer T cells. J Viral Hepat. 18:e415–e422
25. Das R, Rathod SB, Alagarasu K, Arankalle VA, Tripathy AS (2013) Altered expressions of peripheral CD11c, CD80, CD83 markers and associations of HLA class II allele and haplotypes in self-limiting Hepatitis E infection. Hum Immunol 74:277–285
26. Zhao J, Li Y, Jin L, Zhang S, Fan R et al (2012) Natural killer cells are characterized by the concomitantly increased interferon-γ and cytotoxicity in acute resolved hepatitis B patients. PLoS ONE 7:e49135
27. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV (2000) Natural killer T cells activation inhibits hepatitis B virus replication in vivo. J Exp Med 192:921–930
28. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediate cytolysis. Annu Rev Immunol 19:197–223
29. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17:189–220
30. De Maria A, Biassoni R, Fogli M, Rizzi M, Cantoni C et al (2001) Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells. Eur J Immunol 31:3546–3556
31. De Maria A, Fogli M, Costa P, Murdaca G, Puppo F et al (2003) The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33:2410–2418
32. Fogli M, Costa P, Murdaca G, Setti M, Mingari MC et al (2004) Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol 34:2313–2321
33. Golden-Mason L, Cox AL, Randall JA, Cheng L, Rosen HR (2010) Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Hepatology 52:1581–1589
34. Yoon JC, Lim JB, Park JH, Lee JM (2011) Cell-to-cell contact with hepatitis C virus infected cells reduces functional capacity of natural killer cells. J Virol 85:12557–12569
35. Varchetta S, Mele D, Mantovani S, Oliviero B, Cremonesi E et al (2012) Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 56:841–849
36. Pembroke T, Christian A, Jones E, Hills RK, Wang EC et al (2014) The paradox of NKp46 + natural killer cells: drivers of severe hepatitis C virus-induced pathology but in vivo resistance to interferon α treatment. Gut 63:515–524
37. Mao H, Tu W, Liu Y, Qin G, Zheng J et al (2010) Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 84:4148–4157
38. Krzewski K, Gil-Krzewska A, Nguyen V, Peruzzi G, Coligan JE (2013) LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood 121:4672–4683
39. Zhang J, Zhang XF, Zhou C, et al. (2013) Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect. doi: 10.1111/1469-0691.12419
40. Ralainirina N, Poli A, Michel T, Poos L, Andre`s E, Hentges F, Zimmer J (2007) Control of NK cell functions by CD4+ CD25+ regulatory T cells. J Leuko Biol 81:144–153
41. Ghiringhelli F, Ménard C, Terme M (2005) CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor—dependent manner. J Exp Med 202:1075–1085
42. Castriconi R, Cantoni C, Della Chiesa M, Vitale M, Marcenaro E et al (2003) Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc Natl Acad Sci U S A 100:4120–4125
43. Rathod SB, Das R, Thanapati S, Arankalle VA, Tripathy AS (2014) Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting Hepatitis E. J Viral Hepat 21:141–151